Cargando…

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration

INTRODUCTION: We investigated the association of diabetic retinopathy and neuropathy with increased risk of recurrent cardiovascular (CV) events in 6068 patients with type 2 diabetes mellitus (T2DM) and recent acute coronary syndrome (ACS) enrolled in the Evaluation of Lixisenatide in Acute Coronary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seferovic, Jelena P., Bentley-Lewis, Rhonda, Claggett, Brian, Diaz, Rafael, Gerstein, Hertzel C., Køber, Lars V., Lawson, Francesca C., Lewis, Eldrin F., Maggioni, Aldo P., McMurray, John J. V., Probstfield, Jeffrey L., Riddle, Matthew C., Solomon, Scott D., Tardif, Jean-Claude, Pfeffer, Marc A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311850/ https://www.ncbi.nlm.nih.gov/pubmed/30648112 http://dx.doi.org/10.1155/2018/1631263

Ejemplares similares

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial
por: Wijkman, Magnus O., et al.
Publicado: (2020)

Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
por: Wolsk, Emil, et al.
Publicado: (2017)

Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes
por: Wolsk, Emil, et al.
Publicado: (2022)

Response to Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 2013;36:2915–2922
por: Riddle, Matthew C., et al.
Publicado: (2013)

Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes: An analysis of baseline data from the ORIGIN trial
por: Ramachandran, Ambady, et al.
Publicado: (2012)

Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
por: Sabe, Marwa A., et al.
Publicado: (2016)

Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)

Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE‐MI
por: Wang, Xiaowen, et al.
Publicado: (2023)

NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus
por: Malachias, Marcus V. B., et al.
Publicado: (2020)

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program
por: Preiss, David, et al.
Publicado: (2009)

Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial
por: Franek, Edward, et al.
Publicado: (2022)

Left atrial inflow propagation velocity derived by color M-mode Doppler in acute heart failure
por: Johannessen, Øyvind, et al.
Publicado: (2022)

Sex differences in congestive markers in patients hospitalized for acute heart failure
por: Espersen, Caroline, et al.
Publicado: (2021)

Body mass index and B‐lines on lung ultrasonography in chronic and acute heart failure
por: Brainin, Philip, et al.
Publicado: (2020)

Are U‐shaped relationships between risk factors and outcomes artifactual?
por: Shah, Reema, et al.
Publicado: (2022)

Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review
por: Bruin, Jennifer E., et al.
Publicado: (2010)

Creating Composite Indices From Continuous Variables for Research: The Geometric Mean
por: Gerstein, Hertzel C., et al.
Publicado: (2021)

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
por: Konig, Manige, et al.
Publicado: (2021)

HbA(1c) Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression
por: Bethel, M. Angelyn, et al.
Publicado: (2021)

A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
por: Vaduganathan, Muthiah, et al.
Publicado: (2020)

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States
por: Boye, Kristina S., et al.
Publicado: (2019)

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
por: Gerstein, Hertzel C., et al.
Publicado: (2022)

IMPROVE-IT: A Final Closure to Carcinogenicity of Ezetimibe?
por: Lewis, Eldrin F., et al.
Publicado: (2020)

Optimizing Health Coaching for Patients With Type 2 Diabetes Using Machine Learning: Model Development and Validation Study
por: Di, Shuang, et al.
Publicado: (2022)

Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial
por: Hanley, Anthony J., et al.
Publicado: (2010)

The Effect of Oral Antidiabetic Agents on A1C Levels: A systematic review and meta-analysis
por: Sherifali, Diana, et al.
Publicado: (2010)

Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial
por: Gerstein, Hertzel C., et al.
Publicado: (2013)

Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial
por: Fonseca, Vivian, et al.
Publicado: (2013)

Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)

Dysglycemia and a History of Reproductive Risk Factors
por: McDonald, Sarah D., et al.
Publicado: (2008)

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial
por: Riddle, Matthew C, et al.
Publicado: (2021)

Impact of a computerized system for evidence-based diabetes care on completeness of records: a before–after study
por: Roshanov, Pavel S, et al.
Publicado: (2012)

Genetic Neuropathy Due to Impairments in Mitochondrial Dynamics
por: Sharma, Govinda, et al.
Publicado: (2021)

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
por: Riddle, Matthew C., et al.
Publicado: (2021)

Does genetic heterogeneity account for the divergent risk of type 2 diabetes in South Asian and white European populations?
por: Sohani, Zahra N., et al.
Publicado: (2014)

Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
por: Mohammadi-Shemirani, Pedrum, et al.
Publicado: (2020)

MON-636 The Relationship Between Glucose Control & Cognitive Function in People with Diabetes After a Lacunar Stroke
por: Cukierman-Yaffe, Tali, et al.
Publicado: (2020)

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors’ Expert Forum
por: Cefalu, William T., et al.
Publicado: (2018)

Fetal and Neonatal Nicotine Exposure in Wistar Rats Causes Progressive Pancreatic Mitochondrial Damage and Beta Cell Dysfunction
por: Bruin, Jennifer E., et al.
Publicado: (2008)

Longitudinal relationships between glycemic status and body mass index in a multiethnic study: evidence from observational and genetic epidemiology
por: Ishola, Adeola F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6c3vijgonpldhvnq403k8a051e